Bicara Therapeutics Inc. (BCAX) — S-1/A Filings
All S-1/A filings from Bicara Therapeutics Inc.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
Bicara Therapeutics Files IPO Amendment
— Sep 11, 2024 Risk: medium
Bicara Therapeutics Inc. filed an S-1/A amendment on September 11, 2024, for its initial public offering. The company, located at 116 Huntington Avenue, Suite 7 -
Bicara Therapeutics Files S-1/A for IPO
— Sep 6, 2024 Risk: medium
Bicara Therapeutics Inc. filed an S-1/A amendment on September 6, 2024, for its initial public offering. The company, incorporated in Delaware, is based in Bost -
Bicara Therapeutics Files IPO Amendment
— Sep 3, 2024 Risk: medium
Bicara Therapeutics Inc. filed an S-1/A amendment on September 3, 2024, for its initial public offering. The company, located at 116 Huntington Avenue, Suite 70
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX